C4 Ceramide (d18:1/4:0) – 100 mg

Brand:
Cayman
CAS:
74713-58-9
Storage:
-20
UN-No:
Non-Hazardous - /

C4 Ceramide is a bioactive sphingolipid and cell-permeable analog of naturally occurring ceramides.{13011,48234,48235} It inhibits IL-4 production by 16% in EL4 T cells stimulated with phorbol 12-myristate 13-acetate (PMA; Item No. 10008014) when used at a concentration of 10 μM.{13011} C4 Ceramide is cytotoxic to SK-BR-3 and MCF-7/Adr breast cancer cells (IC50s = 15.9 and 19.9 μM, respectively).{48234} C4 Ceramide also increases maturation and stability of cystic fibrosis transmembrane conductance regulator (CFTR) proteins bearing the F508 deletion (F508del) mutation, enhances cAMP-activated chloride secretion, and suppresses secretion of IL-8 in primary epithelial cells isolated from patients with cystic fibrosis.{48235}  

 

Out of stock

SKU: 22528 - Category:

Description

A bioactive sphingolipid; inhibits IL-4 production by 16% in PMA-stimulated EL4 T cells at 10 μM; cytotoxic to SK-BR-3 and MCF-7/Adr breast cancer cells (IC50s = 15.9 and 19.9 μM, respectively); increases maturation and stability of F508del-CFTR proteins, enhances cAMP-activated chloride secretion, and suppresses secretion of IL-8 in primary epithelial cells isolated from patients with cystic fibrosis


Formal name: N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-butanamide

Synonyms:  Cer(d18:1/4:0)|Ceramide (d18:1/4:0)|N-butyroyl-D-erythro-Sphingosine

Molecular weight: 369.6

CAS: 74713-58-9

Purity: ≥95%

Formulation: A crystalline solid


Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Cancer|Cell Death||Research Area|Immunology & Inflammation|Adaptive Immunity||Research Area|Immunology & Inflammation|Pulmonary Diseases|Cystic Fibrosis||Research Area|Lipid Biochemistry|Sphingolipids